Covid-19 ve Vitamin D
Özet
D vitamini, bağışıklık sistemini düzenleyici rolüyle COVID-19 ve diğer viral solunum yolu enfeksiyonlarına karşı potansiyel destek sağlayan önemli bir steroid hormondur. COVID-19 patogenezinde virüs, ACE-2 reseptörlerine bağlanarak hücreye girer ve bazı ağır vakalarda "sitokin fırtınası" olarak adlandırılan hiperinflamatuar bir yanıta yol açarak hayati risk oluşturur. D vitamini ise proinflamatuar sitokinleri (IL-1, IL-6, TNF-alfa) azaltıp antiinflamatuar IL-10 düzeyini artırarak bu aşırı bağışıklık yanıtını baskılayabilir ve doku hasarını önleyebilir. Yapılan ekolojik ve retrospektif çalışmalar, serum 25(OH)D düzeyi düşük (<20 ng/ml) olan COVID-19 hastalarında klinik seyrin daha kötü, ölüm oranlarının daha yüksek olduğunu; yeterli düzeydeki (>30 ng/ml) bireylerde ise hipoksi riski ve mortalitenin azaldığını göstermektedir. Enfeksiyondan korunma veya hastalık şiddetini hafifletmek için serum konsantrasyonunun 40-50 ng/ml üzerine çıkarılması ve günlük 1000-2000 IU vitamin D3 takviyesi önerilmektedir. Koruyucu etki günlük veya haftalık düzenli kullanımlarda görülürken, yüksek doz bolus rejimlerinde aynı başarı elde edilememiştir. Aşırı yüksek dozlar (günlük 10.000-40.000 IU) hiperkalsemi ve doku kalsifikasyonu gibi toksisite riskleri taşımaktadır. D vitamini tek başına bir mucize olmasa da, virüs replikasyonunu kontrol etme ve hiperinflamasyonu azaltma potansiyeliyle destek tedavide klinik araştırmalara değer bir ajan olarak öne çıkmaktadır.
Vitamin D is a crucial steroid hormone that acts as an immunomodulator, offering potential support against COVID-19 and other viral respiratory infections. In COVID-19 pathogenesis, the virus enters cells via ACE-2 receptors, which can lead to a life-threatening "cytokine storm" through a hyperinflammatory response in severe cases. Vitamin D can suppress this excessive immune response and prevent tissue damage by decreasing pro-inflammatory cytokines (such as IL-1, IL-6, TNF-alpha) while increasing anti-inflammatory IL-10 levels. Ecotoxicological and retrospective studies demonstrate that COVID-19 patients with low serum 25(OH)D levels (<20 ng/ml) experience poorer clinical outcomes and higher mortality rates, whereas individuals with sufficient levels (>30 ng/ml) show reduced risks of hypoxia and death. To prevent infection or mitigate disease severity, elevating serum concentrations above 40-50 ng/ml and maintaining a daily supplementation of 1000-2000 IU of vitamin D3 is recommended. While the protective effect is observed with regular daily or weekly intake, high-dose bolus regimens have not yielded the same success. Excessive doses (10,000-40,000 IU daily) carry toxicity risks, including hypercalcemia and tissue calcification. Although vitamin D is not a standalone miracle cure, its potential to control viral replication and reduce hyperinflammation makes it a noteworthy agent in supportive treatment that warrants further clinical research.
Referanslar
Tyrrell DAJ, Bynoe ML. Cultivation of a novel type of common-cold virus in organ cultures. BMJ. 1965;1:1467–70.
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–3.
McGonagle D, Sharif K, O'Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537.
Lu R, Zhao X, Li J, Niu P, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.
Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020.
Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev. 2019;40:1109–51.
Azrielant S, Shoenfeld Y. Vitamin D and the immune system. Isr Med Assoc J. 2017;19(8):510–1.
Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–3.
Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7(6):4240–70.
Sly LM, Lopez M, Nauseef WM, Reiner NE. 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem. 2001;276(38):35482–93.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2002032.
Zhou Y, Fu B, Zheng X, et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Sci. Rev. 2020:nwaa041. doi: 10.1093/nsr/nwaa041.
Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7(6):4240–70.
Arboleda JF, Urcuqui-Inchima S. Vitamin D supplementation: a potential approach for coronavirus/covid-19 therapeutics? Front Immunol. 2020;11:1523.
Hansdottir S, Monick MM, Hinde SL, et al. Hunninghake G.W. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J. Immunol. 2008;181:7090–9.
Heulens N, Korf H, Mathyssen C, et al. 1,25-Dihydroxyvitamin D modulates antibacterial and inflammatory response in human cigarette smoke-exposed macrophages. PLoS One. 2016;11:e0160482. doi: 10.1371/journal.pone.0160482.
Zittermann A, Pilz S, Hoffmann H, März W. Vitamin D and airway infections: a European perspective. Eur J Med Res. 2016;21:14.
Robertsen S, Grimnes G, Melbye H. Association between serum 25-hydroxyvitamin D concentration and symptoms of respiratory tract infection in a Norwegian population: the Tromsø Study. Public Health Nutr. 2014;17(4):780–6.
Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.
Berry DJ, Hesketh K, Power C, Hyppönen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br. J. Nutr. 2011;106:1433–40.
Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006;134:1129–40.
Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third national health and nutrition examination survey. Arch. Intern. Med. 2009;169:384.
Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. 2020.
Alipio M. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus-2019 (COVID-19). 2020.
Jain SK, Parsanathan R. Can vitamin D and L-cysteine co-supplementation reduce 25(OH)-vitamin D deficiency and the mortality associated with COVID-19 in African Americans? J Am Coll Nutr. 2020:1–6.
Maghbooli Z., Sahraian M.A., Ebrahimi M, et al. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One. 2020;15:e0239799. doi: 10.1371/journal.pone.0239799
Raisi-Estabragh Z, McCracken C, Bethell MS, et al. Greater risk of severe COVID-19 in non-White ethnicities is not explained by cardiometabolic, socioeconomic, or behavioural factors, or by 25 (OH)-vitamin D status: study of 1,326 cases from the UK Biobank. 2020.
Carter SJ, Baranauskas MN, Fly AD. Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID-19 Pandemic. Obesity (Silver Spring). 2020 Jul;28(7):1176-7.
Mohan M, Cherian JJ, Sharma A. Exploring links between vitamin D deficiency and COVID-19. PLoS Pathog. 2020 Sep 18;16(9):e1008874. doi: 10.1371/journal.ppat.1008874.
NIH Office of Dietary Supplements. Vitamin D fact sheet for health professionals. Updated March 24, 2020. Available at: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. Accessed August 2, 2020.
Simonson W. Vitamin D dosing considerations in COVID-19. Geriatr Nurs. 2020 Sep-Oct;41(5):648-649. doi: 10.1016/j.gerinurse.2020.08.011.
Link, R. Vitamin D3 vs. Vitamin D2 and how to obtain both. Dr. Axe.com, April 30, 2019. Available at: https://draxe.com/nutrition/vitamin-d3/. Accessed July 28, 2020.
McNeil AM, Wesner E. Sun protection and vitamin D. Skin Cancer Found, Sun Skin News. May 14. 2018 https://www.skincancer.org/blog/sun-protection-and-vitamin-d/ Available at: Accessed August 1, 2020.
Grant WB, Al Anouti F, Moukayed M. Targeted 25-hydroxyvitamin D concentration measurements and vitamin D3 supplementation can have important patient and public health benefits. Eur J Clin Nutr. 2020 Mar;74(3):366-76.
Grant WB, Lahore H, McDonnell S, et al. Vitamin D supplementation could prevent and treat influenza, coronavirus, and pneumonia infections. Med. Pharmacol. 2020 doi: 10.20944/preprints202003.0235.v1.
Delomas C, Hertzog M, Vogel T, Lang PO. Vitamin D Supplementation in nursing home residents: randomized single Cholecalciferol loading protocol vs. individualized loading dose Regimen. J Nutr Health Aging. 2017;21(4):421–8.
Han JE, Jones JL, Tangpricha V, et al. High Dose Vitamin D Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized Controlled Trial. J Clin Transl Endocrinol 2016, 4, 59-65.
Dauber A, Nguyen TT, Sochett E, et al. Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab. 2012;97(2):268–74.
Robien K, Oppeneer SJ, Kelly JA, Hamilton-Reeves JM. Drug–vitamin D interactions: a systematic review of the literature. Nutr Clin Pract. 2013;28(2):194–208.
Kumar R, Rathi H, Haq A, et al. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021 Jan 15;292:198235. doi: 10.1016/j.virusres.2020.198235. Epub 2020 Nov 21.
